enoxacin has been researched along with Breast Neoplasms in 3 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Not only in melanoma, but also in MCF7 breast carcinoma and A2780 ovarian carcinoma cells overexpressing MdmX." | 1.46 | A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein. ( Growkova, K; Mlcochova, J; Radova, L; Slaby, O; Stetkova, M; Uldrijan, S; Valcikova, B; Valianatos, G; Verlande, A; Vyhnakova, M, 2017) |
| "Enoxacin is a small molecule that stimulates RNA interference (RNAi) and acts as a growth inhibitor selectively in cancer but not in untransformed cells." | 1.46 | Click Quantitative Mass Spectrometry Identifies PIWIL3 as a Mechanistic Target of RNA Interference Activator Enoxacin in Cancer Cells. ( Abell, NS; Cañeque, T; Mercado, M; Rodriguez, R; Xhemalce, B, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valianatos, G | 1 |
| Valcikova, B | 1 |
| Growkova, K | 1 |
| Verlande, A | 1 |
| Mlcochova, J | 1 |
| Radova, L | 1 |
| Stetkova, M | 1 |
| Vyhnakova, M | 1 |
| Slaby, O | 1 |
| Uldrijan, S | 1 |
| Vracar, TC | 1 |
| Zuo, J | 1 |
| Park, J | 1 |
| Azer, D | 1 |
| Mikhael, C | 1 |
| Holliday, SA | 1 |
| Holsey, D | 1 |
| Han, G | 1 |
| VonMoss, L | 1 |
| Neubert, JK | 1 |
| Rody, WJ | 1 |
| Chan, EKL | 1 |
| Holliday, LS | 1 |
| Abell, NS | 1 |
| Mercado, M | 1 |
| Cañeque, T | 1 |
| Rodriguez, R | 1 |
| Xhemalce, B | 1 |
3 other studies available for enoxacin and Breast Neoplasms
| Article | Year |
|---|---|
A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
Topics: Alternative Splicing; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Damage; | 2017 |
Enoxacin and bis-enoxacin stimulate 4T1 murine breast cancer cells to release extracellular vesicles that inhibit osteoclastogenesis.
Topics: Animals; Bone Marrow Cells; Bone Remodeling; Breast Neoplasms; Calcitriol; Cell Proliferation; Dipho | 2018 |
Click Quantitative Mass Spectrometry Identifies PIWIL3 as a Mechanistic Target of RNA Interference Activator Enoxacin in Cancer Cells.
Topics: Argonaute Proteins; Breast Neoplasms; Cell Proliferation; Enoxacin; Female; Humans; Mass Spectrometr | 2017 |